uniQure (QURE) Long-Term Deferred Tax (2020 - 2026)
uniQure (QURE) posted quarterly Long-Term Deferred Tax of $6.4 million for Q2 2026, down 29.44% year-over-year from $9.0 million in Q2 2025, and down 22.36% quarter-over-quarter from $8.2 million in Q1 2026.
uniQure (QURE) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
uniQure's Long-Term Deferred Tax history runs 7 years deep, the most recent figure standing at $6.4 million for Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 29.44% year-over-year to $6.4 million; the TTM figure through Jun 2026 stood at $6.4 million (down 29.44% YoY), while the FY2025 annual figure was $8.7 million, down 12.2% from the prior year.
- Long-Term Deferred Tax for Q2 2026 stood at $6.4 million, down from $8.2 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $15.4 million in Q1 2022, with the low at $6.4 million in Q2 2026.
- The 5-year median for Long-Term Deferred Tax is $11.2 million (2024), against an average of $11.4 million.
- The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax decreased 4.71% in 2022, then dropped 29.44% in 2026.
- uniQure's Long-Term Deferred Tax stood at $14.5 million in 2022, then slipped by 15.5% to $12.3 million in 2023, then slipped by 19.71% to $9.9 million in 2024, then retreated by 12.2% to $8.7 million in 2025, then dropped by 26.48% to $6.4 million in 2026.
- Business Quant data shows QURE's Long-Term Deferred Tax at $6.4 million in Q2 2026, $8.2 million in Q1 2026, and $8.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.36 Mn |
| Mar 31, 2026 | 8.19 Mn |
| Dec 31, 2025 | 8.65 Mn |
| Sep 30, 2025 | 8.77 Mn |
| Jun 30, 2025 | 9.02 Mn |
| Mar 31, 2025 | 9.39 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 10.86 Mn |
| Jun 30, 2024 | 10.72 Mn |
| Mar 31, 2024 | 11.59 Mn |
| Dec 31, 2023 | 12.28 Mn |
| Sep 30, 2023 | 12.35 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 14.33 Mn |
| Dec 31, 2022 | 14.53 Mn |
| Sep 30, 2022 | 14.63 Mn |
| Jun 30, 2022 | 15.05 Mn |
| Mar 31, 2022 | 15.44 Mn |
| Dec 31, 2021 | 15.65 Mn |
| Sep 30, 2021 | 15.72 Mn |